Nonetheless, COL11A1 offers several advantages as a biomarker: it demonstrates high sensitivity and specificity, reflects tumor stromal activity, and provides information independent of traditional epithelial markers such as ER, PR, HER2, or PD-L1 [2,72]. This evidence concerns the gene COL11A1 and neoplasm.